Ilumetri ( Tildrakizumab ): an anti-IL-23 biologic for plaque psoriasis
CPE point: 1 per event
This is an in-service training for the staff of St. Teresa's Hospital & St. Paul's Hospital
Date:
2026-07-10
Time:
5:30pm to 6:30pm
Organising Institute:
St. Teresa's Hospital & St. Paul's Hospital
Speaker:
M.Phil (Pharm), Candy Hung, Medical Affairs Manager, Rxilient Medical
Related CPE Activities:
